Literature DB >> 10203509

Comparison of E-test and broth microdilution methods for antifungal drug susceptibility testing of molds.

A Szekely1, E M Johnson, D W Warnock.   

Abstract

We compared the E test with a broth microdilution method, performed according to National Committee for Clinical Laboratory Standards document M27-A guidelines, for determining the in vitro susceptibilities of 90 isolates of pathogenic molds (10 Absidia corymbifera, 10 Aspergillus flavus, 10 Aspergillus fumigatus, 10 Aspergillus niger, 10 Aspergillus terreus, 10 Exophiala dermatitidis, 10 Fusarium solani, 10 Scedosporium apiospermum, 5 Scedosporium prolificans, and 5 Scopulariopsis brevicaulis). Overall, there was 71% agreement between the results of the two methods for amphotericin B (E-test MICs within +/-2 log2 dilutions of broth microdilution MICs) and 88% agreement with the results for itraconazole. The overall levels of agreement (within +/-2 log2 dilutions) were >/=80% for 5 of the 10 species tested against amphotericin B and 8 of the 10 species tested against itraconazole. The best agreement between the results was seen with A. fumigatus and A. terreus (100% of results for both agents within +/-2 log2 dilutions). The poorest agreement was seen with S. apiospermum, S. prolificans, and S. brevicaulis tested against amphotericin B (20% of results within +/-2 log2 dilutions). In every instance, this low level of agreement was due to isolates for which the broth microdilution MICs were low but for which the E-test MICs were much higher. The E test appears to be a suitable alternative procedure for testing the susceptibility of Aspergillus spp. and some other molds to amphotericin B or itraconazole.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10203509      PMCID: PMC84808     

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  23 in total

1.  Lot-to-lot variability of antibiotic medium 3 used for testing susceptibility of Candida isolates to amphotericin B.

Authors:  M Lozano-Chiu; P W Nelson; M Lancaster; M A Pfaller; J H Rex
Journal:  J Clin Microbiol       Date:  1997-01       Impact factor: 5.948

2.  Multicenter evaluation of proposed standardized procedure for antifungal susceptibility testing of filamentous fungi.

Authors:  A Espinel-Ingroff; M Bartlett; R Bowden; N X Chin; C Cooper; A Fothergill; M R McGinnis; P Menezes; S A Messer; P W Nelson; F C Odds; L Pasarell; J Peter; M A Pfaller; J H Rex; M G Rinaldi; G S Shankland; T J Walsh; I Weitzman
Journal:  J Clin Microbiol       Date:  1997-01       Impact factor: 5.948

3.  Comparison of Etest and National Committee for Clinical Laboratory Standards broth macrodilution method for azole antifungal susceptibility testing.

Authors:  A L Colombo; F Barchiesi; D A McGough; M G Rinaldi
Journal:  J Clin Microbiol       Date:  1995-03       Impact factor: 5.948

Review 4.  Mechanisms and clinical impact of antifungal drug resistance.

Authors:  H Vanden Bossche; D W Warnock; B Dupont; D Kerridge; S Sen Gupta; L Improvisi; P Marichal; F C Odds; F Provost; O Ronin
Journal:  J Med Vet Mycol       Date:  1994

5.  Detection of amphotericin B-resistant Candida isolates in a broth-based system.

Authors:  J H Rex; C R Cooper; W G Merz; J N Galgiani; E J Anaissie
Journal:  Antimicrob Agents Chemother       Date:  1995-04       Impact factor: 5.191

6.  Antifungal susceptibility testing using the E test: comparison with the broth macrodilution technique.

Authors:  S C Chen; M L O'Donnell; S Gordon; G L Gilbert
Journal:  J Antimicrob Chemother       Date:  1996-02       Impact factor: 5.790

7.  Comparison of Etest and National Committee for Clinical Laboratory Standards broth macrodilution method for antifungal susceptibility testing: enhanced ability to detect amphotericin B-resistant Candida isolates.

Authors:  A Wanger; K Mills; P W Nelson; J H Rex
Journal:  Antimicrob Agents Chemother       Date:  1995-11       Impact factor: 5.191

8.  Activities of amphotericin B and antifungal azoles alone and in combination against Pseudallescheria boydii.

Authors:  T J Walsh; J Peter; D A McGough; A W Fothergill; M G Rinaldi; P A Pizzo
Journal:  Antimicrob Agents Chemother       Date:  1995-06       Impact factor: 5.191

9.  Etest for antifungal susceptibility testing of yeasts.

Authors:  A Espinel-Ingroff
Journal:  Diagn Microbiol Infect Dis       Date:  1994-08       Impact factor: 2.803

10.  Evaluation of the E test system versus a microtitre broth method for antifungal susceptibility testing of yeasts against fluconazole and itraconazole.

Authors:  A L Colombo; F Barchiesi; D A McGough; A W Fothergill; M G Rinaldi
Journal:  J Antimicrob Chemother       Date:  1995-07       Impact factor: 5.790

View more
  36 in total

1.  Evaluation of Etest method for determining posaconazole MICs for 314 clinical isolates of Candida species.

Authors:  M A Pfaller; S A Messer; K Mills; A Bolmström; R N Jones
Journal:  J Clin Microbiol       Date:  2001-11       Impact factor: 5.948

Review 2.  Antifungal susceptibility testing: practical aspects and current challenges.

Authors:  J H Rex; M A Pfaller; T J Walsh; V Chaturvedi; A Espinel-Ingroff; M A Ghannoum; L L Gosey; F C Odds; M G Rinaldi; D J Sheehan; D W Warnock
Journal:  Clin Microbiol Rev       Date:  2001-10       Impact factor: 26.132

3.  Collaborative evaluation of optimal antifungal susceptibility testing conditions for dermatophytes.

Authors:  Belkys Fernández-Torres; Francisco J Cabañes; Alfonso J Carrillo-Muñoz; Alexandre Esteban; Isabel Inza; Lourdes Abarca; Josep Guarro
Journal:  J Clin Microbiol       Date:  2002-11       Impact factor: 5.948

Review 4.  In vitro analyses, animal models, and 60 clinical cases of invasive Aspergillus terreus infection.

Authors:  William J Steinbach; John R Perfect; Wiley A Schell; Thomas J Walsh; Daniel K Benjamin
Journal:  Antimicrob Agents Chemother       Date:  2004-09       Impact factor: 5.191

5.  The T788G mutation in the cyp51C gene confers voriconazole resistance in Aspergillus flavus causing aspergillosis.

Authors:  Wei Liu; Yi Sun; Wei Chen; Weixia Liu; Zhe Wan; Dingfang Bu; Ruoyu Li
Journal:  Antimicrob Agents Chemother       Date:  2012-02-06       Impact factor: 5.191

6.  Evaluation of broth microdilution antifungal susceptibility testing conditions for Trichophyton rubrum.

Authors:  D A Santos; J S Hamdan
Journal:  J Clin Microbiol       Date:  2005-04       Impact factor: 5.948

7.  Amphotericin B and voriconazole susceptibility profiles for the Fusarium solani species complex: comparison between the E-test and CLSI M38-A2 microdilution methodology.

Authors:  A Debourgogne; S de Hoog; A Lozniewski; M Machouart
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2011-07-09       Impact factor: 3.267

8.  Assessment of efficacy of antifungals against Aspergillus fumigatus: value of real-time bioluminescence imaging.

Authors:  Célimène Galiger; Matthias Brock; Grégory Jouvion; Amélie Savers; Marianna Parlato; Oumaïma Ibrahim-Granet
Journal:  Antimicrob Agents Chemother       Date:  2013-04-15       Impact factor: 5.191

Review 9.  Molecular Tools for the Detection and Deduction of Azole Antifungal Drug Resistance Phenotypes in Aspergillus Species.

Authors:  Anna Dudakova; Birgit Spiess; Marut Tangwattanachuleeporn; Christoph Sasse; Dieter Buchheidt; Michael Weig; Uwe Groß; Oliver Bader
Journal:  Clin Microbiol Rev       Date:  2017-10       Impact factor: 26.132

Review 10.  Infections caused by Scedosporium spp.

Authors:  Karoll J Cortez; Emmanuel Roilides; Flavio Quiroz-Telles; Joseph Meletiadis; Charalampos Antachopoulos; Tena Knudsen; Wendy Buchanan; Jeffrey Milanovich; Deanna A Sutton; Annette Fothergill; Michael G Rinaldi; Yvonne R Shea; Theoklis Zaoutis; Shyam Kottilil; Thomas J Walsh
Journal:  Clin Microbiol Rev       Date:  2008-01       Impact factor: 26.132

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.